Whole-body interdiction of lengthening of telomeres: A proposal for cancer prevention

Frontiers in Bioscience

Volumn 10, Issue SUPPL. 1, 2005, Pages 2420-2429

  De Grey, Aubrey D N J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

ALT; Cancer; Chemoresistance; Gene Targeting; Immunosenescence; Review; Stem Cells; Telomerase; Telomeres; Tumor

Indexed keywords

ALANINE AMINOTRANSFERASE; TELOMERASE; TEMOZOLOMIDE;

ARTICLE; B LYMPHOCYTE; BLOOD CELL; CANCER; CANCER CELL; CANCER PREVENTION; CANCER THERAPY; GENE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HUMAN; IN VITRO STUDY; MITOSIS RATE; NONHUMAN; SOMATIC CELL; STEM CELL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TELOMERE; THERAPY; TISSUE; TUMOR; WHOLE BODY INTERDICTION OF LENTHENING OF TELOMERE;

EID: 21344437079     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1707     Document Type: Article

References (65)

1. S. Okamoto, R. Watanabe, S. Takahashi, T. Mori, T. Izeki, H. Nagayama, A. Ishida, N. Takayama, K. Yokoyama, A. Tojo, S. Asano & Y. Ikeda: Long-term follow-up of allogeneic bone marrow transplantation after reduced-intensity conditioning in patients with chronic myelogenous leukemia in the chronic phase. Int J Hematol 75, 493-498 (2002)
2. H. M. Lokhorst, A. Schattenberg, J. J. Cornelissen, M. H. van Oers, W. Fibbe, I. Russell, N. W. Donk & L. F. Verdonck: Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome. J Clin Oncol 18, 3031-3037 (2000)
3. X. Wang, J. Tang, J. Wu, J. Feng, L. Pang, A. Dai & X. Zheng: Preoperative high-dose chemotherapy with peripheral blood stem cell support as a primary management of locally advanced breast cancer. Bone Marrow Transplant 27, 345-346 (2001)
4. R. K. Jain, L. L. Munn & D. Fukumura: Dissecting tumour pathophysiology using intravital microscopy. Nat Rev Cancer 2, 266-276 (2002)
5. M. Al-Hajj M & M. F. Clarke: Self-renewal and solid tumor stem cells. Oncogene 23, 7274-7282 (2004)
6. A. D. N. J. de Grey, F. C. Campbell, I. Dokal, L. J. Fairbairn, G. J. Graham, C. A. B. Jahoda & A. C. G. Porter: Total deletion of in vivo telomere elongation capacity: an ambitious but possibly ultimate cure for all age-related human cancers. Ann N Y Acad Sci 1019, 147-170 (2004)
7. A. D. N. J. de Grey, B. N. Ames, J. K. Andersen, A. Bartke, J. Campisi, C. B. Heward, R. J. M. McCarter & G. Stock: Time to talk SENS: critiquing the immutability of human aging. Ann N Y Acad Sci 959, 452-462 (2002)
8. A. D. N. J. de Grey: An engineer's approach to the development of real anti-aging medicine. Sci Aging Knowledge Environ 2003, VP1 (2003)
9. A. D. N. J. de Grey: The foreseeability of real anti-aging medicine: focusing the debate. Exp Gerontol 38, 927-934 (2003)
10. R. K. Moyzis, J. M. Buckingham, L. S. Cram, M. Dani, L. L. Deaven, M. D. Jones, J. Meyne, R. L. Ratliff & J. R. Wu: A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85, 6622-6626 (1988)
11. A. M. Olovnikov: Principle of marginotomy in template synthesis of polynucleotides. Dokl Akad Nauk SSSR 201, 1496-1499 (1971)
12. J. D. Watson: Origin of concatemeric T7 DNA. Nat New Biol 239, 197-201 (1972)
13. D. Shore: Telomeres - unsticky ends. Science 281, 1818-1819 (1998)
14. T. de Lange: Protection of mammalian telomeres. Oncogene 21, 532-540 (2002)
15. M. L. Pardue & P. G. DeBaryshe: Retrotransposons provide an evolutionarily robust non-telomerase mechanism to maintain telomeres. Annu Rev Genet 37, 485-511 (2003)
16. C. W. Roth, F. Kobeski, M. F. Walter & H. Biessmann: Chromosome end elongation by recombination in the mosquito Anopheles gambiae. Mol Cell Biol 17, 5176-5183 (1997)
17. E. H. Blackburn: Structure and function of telomeres. Nature 350, 569-573 (1991)
18. J. W. Shay & S. Bacchetti: A survey of telomerase activity in human cancer. Eur J Cancer 33, 787-791 (1997)
19. R. R. Reddel: The role of senescence and immortalization in carcinogenesis. Carcinogenesis 21, 477-484 (2000)
20. R. R. Reddel: Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett 194, 155-162 (2003)
21. L. Hayflick & P. S. Moorhead: The serial cultivation of human diploid cell strains. Exp Cell Res 25, 585-621 (1961)
22. C. M. Counter, J. Gupta, C. B. Harley, B. Leber & S. Bacchetti: Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85, 2315-2320 (1995)
23. J. P. de Magalhaes & O. Toussaint: Telomeres and telomerase: a modern fountain of youth? Rejuvenation Res 7, 126-133 (2004)
24. J. Campisi: Cancer, aging and cellular senescence. In Vivo 14, 183-188 (2000)
25. T. Aigner, J. Rose, J. Martin & J. Buckwalter: Aging theories of primary osteoarthritis: from epidemiology to molecular biology. Rejuvenation Res 7, 134-145 (2004)
26. M. Kakihana, N. Yahata, T. Hirano, H. Honda, N. Ikeda, N. Kawate, C. Konaka, Y. Ebihara, K. Ohyashiki & H. Kato: Telomerase activity during carcinogenesis in the bronchus. Oncol Rep 9, 43-49 (2002)
27. J. Yui, C. P. Chiu & P. M. Lansdorp: Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood 91, 3255-3262 (1998)
28. S. Sell S & G. B. Pierce: Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest 70, 6-22 (1994)
29. M. A. Blasco: Mammalian telomeres and telomerase: why they matter for cancer and aging. Eur J Cell Biol 82, 441-446 (2003)
30. K. Nakamura, T. Taniguchi, Y. Funahashi & K. Yoshimatsu: Effects of ER-37328 on primary tumor, liver metastasis, and life span in a murine colon 38 orthotopic transplantation model. Mol Cancer Ther 2, 59-64 (2003)
31. K. L. Rudolph, S. Chang, H. W. Lee, M. A. Blasco, G. J. Gottlieb, C. Greider & R. A. DePinho: Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701-712 (1999)
32. I. Dokal: Dyskeratosis congenita in all its forms. Br J Haematol 110, 768-779 (2000)
33. P. J. Mason: Stem cells, telomerase and dyskeratosis congenita. BioEssays 25, 126-133 (2003)
34. P. L. Weiden: Allogeneic bone marrow transplantation. Crit Rev Clin Lab Sci 19, 173-186 (1983)
35. A. Wilson, M. J. Murphy, T. Oskarsson, K. Kaloulis, M. D. Bettess, G. M. Oser, A. C. Pasche, C. Knabenhans, H. R. Macdonald & A. Trumpp: c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 18, 2747-2763 (2004)
36. J. Krosl, N. Beslu, N. Mayotte, R. K. Humphries & G. Sauvageau: The competitive nature of HOXB4-transduced HSC is limited by PBX1: the generation of ultra-competitive stem cells retaining full differentiation potential. Immunity 18, 561-571 (2003)
37. K. M. Vasquez, K. Marburger, Z. Intody & J. H. Wilson: Manipulating the mammalian genome by homologous recombination. Proc Natl Acad Sci USA 98, 8403-8410 (2001)
38. F. M. Stewart, S. Zhong, J. Wuu, C. Hsieh, S. K. Nilsson & P. J. Quesenberry: Lymphohematopoietic engraftment in minimally myeloablated hosts. Blood 91, 3681-3687 (1998)
39. C. Ferraris, G. Chevalier, B. Favier, C. A. B. Jahoda & D. Dhouailly: Adult corneal epithelium basal cells possess the capacity to activate epidermal, pilosebaceous and sweat gland genetic programs in response to embryonic dermal stimuli. Development 127, 5487-5495 (2000)
40. F. M. Watt: Epidermal stem cells: markers, patterning and the control of stem cell fate. Philos Trans R Soc Lond B Biol Sci 353, 831-837 (1998)
41. E. Puchelle & B. Peault: Human airway xenograft models of epithelial cell regeneration. Respir Res 1, 125-128 (2000)
42. I. S. Tait, J. I. Penny & F. C. Campbell: Does neomucosa induced by small bowel stem cell transplantation have adequate function? Am J Surg 169, 120-125 (1995)
43. M. Stelzner, V. D. Hoagland & J. D. Woolman: Identification of optimal harvest sites of ileal stem cells for treatment of bile acid malabsorption in a dog model. J Gastrointest Surg 7, 516-522 (2003)
44. A. C. Groth & M. P. Calos: Phage integrases: biology and applications. J Mol Biol 335, 667-678 (2004)
45. A. C. Groth, M. Fish, R. Nusse & M. P. Calos: Construction of transgenic Drosophila by using the site-specific integrase from phage phiC31. Genetics 166, 1775-1782 (2004)
46. B. Thyagarajan, E. C. Olivares, R. P. Hollis, D. S. Ginsburg & M. P. Calos: Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol 21, 3926-3934 (2001)
47. C. R. Sclimenti, B. Thyagarajan & M. P. Calos: Directed evolution of a recombinase for improved genomic integration at a native human sequence. Nucleic Acids Res 29, 5044-5051 (2001)
48. J. L. Abkowitz, D. Golinelli, D. E. Harrison & P. Guttorp: In vivo kinetics of murine hemopoietic stem cells. Blood 96, 3399-3405 (2000)
49. E. J. Van Scott, T. M. Ekel & R. Auerbach: Determinants of rate and kinetics of cell division in scalp hair. J Invest Dermatol 41, 269-273 (1963)
50. E. Marshman, C. Booth & C. S. Potten: The intestinal epithelial stem cell. BioEssays 24, 91-98 (2002)
51. M. Loeffler, A. Birke, D. Winton & C. S. Potten: Somatic mutation, monoclonality and stochastic models of stem cell organization in the intestinal crypt. J Theor Biol 160, 471-491 (1993)
52. R. W. Taylor, M. J. Barron, G. M. Borthwick, A. Gospel, P. F. Chinnery, D. C. Samuels, G. A. Taylor, S. M. Plusa, S. J. Needham, L. C. Greaves, T. B. L. Kirkwood & D. M. Turnbull: Mitochondrial DNA mutations in human colonic crypt stem cells. J Clin Invest 112, 1351-1360 (2003)
53. H. W. Lee, M. A. Blasco, G. J. Gottlieb, J. W. Horner, C. W. Greider & R. A. DePinho: Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569-574 (1998)
54. R. J. Phillips, M. Judge, D. Webb & J. I. Harper: Dyskeratosis congenita: delay in diagnosis and successful treatment of pancytopenia by bone marrow transplantation. Br J Dermatol 127, 278-280 (1992)
55. E. Herrera, C. Martinez-A & M. A. Blasco: Impaired germinal center reaction in mice with short telomeres. EMBO J 19, 472-481 (2000)
56. D. L. Radu, M. E. Weksler & C. A. Bona: Maintenance of size and function of influenza virus hemagglutinin specific transgenic T-cell clone during life. J Cell Mol Med 5, 388-396 (2001)
57. T. M. Bryan, A. Englezou, J. Gupta, S. Bacchetti & R. R. Reddel: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14, 4240-4248 (1995)
58. T. M. Bryan & R. R. Reddel: Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur J Cancer 33, 767-773 (1997)
59. L. Maringele & D. Lydall: Telomerase- and recombination-independent immortalization of budding yeast. Genes Dev 18, 2663-2675 (2004)
60. T. R. Yeager, A. A. Neumann, A. Englezou, L. I. Huschtscha, J. R. Noble & R. R. Reddel: Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res 59, 4175-4179 (1999)
61. S. L. Gerson: MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer 4, 296-307 (2004)
62. D. A. Hobin & L. J. Fairbairn: Genetic chemoprotection with mutant O6-alkylguanine-DNA-alkyltransferases. Curr Gene Ther 2, 1-8 (2002)
63. G. Pawelec & R. Forsey: Immunosenescence: what is it and what can be done about it? Rejuvenation Res 7, 61-64 (2004)
64. I. Messaoudi, J. Lemaoult, J. A. Guevara-Patino, B. M. Metzner & J. Nikolich-Zugich: Age-related CD8 T cell clonal expansions constrict CD8 T cell repertoire and have the potential to impair immune defense. J Exp Med 200, 1347-1358 (2004)
65. R. B. Effros: Replicative senescence of CD8 T cells: effect on human ageing. Exp Gerontol 39, 517-524 (2004)